generic drugs

In recent weeks, we have witnessed a heated debate between doctors and master pharmacists about the right and procedure for prescribing medicines for Bulgarian patients. Pharmacists are starting from the point of view that due to the state of emergency, there is a possibility that certain medicines or their analogues will become scarce goods. Here …

The COVID-19 epidemic in Bulgaria is developing. Speculation about whether it is in its beginning, middle and end should be left aside, as the main goal at the moment should be to minimize the risk of the widespread spread of the virus. Even now, predictions about its development are …

This article is a summary of our new analysis and proposal for reform of the drug policy in Bulgaria. What did we find out? The analysis covers 56% of health-insured persons and 40% of the funds reimbursed by the NHIF and includes 4 groups of diseases: cardiovascular, malignant tumors, diabetes mellitus and rheumatoid. In 2016, over 2.5 million health-insured …

Uncontrollably growing budget for medicines Over the past few years, the growth in the cost of medicines paid by the NHIF has been between 15-20% on an annual basis. In 2018, the costs reached 1 billion, and the primary reaction of the institutions was the so-called limitation of payment for innovative medicines, entitled "moratorium", which fell ...

What are the critical points that the healthcare system will face by the end of 2018? Over the past few months, we have witnessed a number of scandals in the healthcare sector and an unceasing whirlpool of ideas, proposals and policies that, after an attempt to be put into practice, are rejected by the system in every possible way and …

What happens when a country has a limited public resource for healthcare that has no clear owner? Quite simply – it is distributed according to the needs of certain market players, and the entire system starts bidding for a piece of it. What happens? This is also the case with …

|Full text of the analysis| Summary and conclusions from the analysis of the sartan group: The results of this study confirm the conclusions of previous analyses, such as the World Bank's 2015 analysis, as well as good practices from EU countries, and quantify the positive effects of implementing a progeneric policy within the framework of …

This text is an analysis of the government's health care program for the period 2017-2021, published on 02.08.2017 on the website of the Council of Ministers here. Prevention and Prevention: The over-financing of hospital care in the country has created the prerequisites for heavy lobbying in the formation of the budget of the National Health Insurance Fund (NHIF). The costs …

What is the problem with medicines? The problems in Bulgarian healthcare are not only with medicines. The problem of the entire system is actually the inefficient spending of funds, which is getting worse every year. The second problem is that since the establishment of the National Health Insurance Fund (NHIF) until today, its budget has been growing by an average of about 7% per …